OA09893A - Transvascular and intracellular delivery of lipidized proteins. - Google Patents

Transvascular and intracellular delivery of lipidized proteins.

Info

Publication number
OA09893A
OA09893A OA60481A OA60481A OA09893A OA 09893 A OA09893 A OA 09893A OA 60481 A OA60481 A OA 60481A OA 60481 A OA60481 A OA 60481A OA 09893 A OA09893 A OA 09893A
Authority
OA
OAPI
Prior art keywords
transvascular
intracellular delivery
lipidized proteins
lipidized
proteins
Prior art date
Application number
OA60481A
Inventor
Bernard Malfroy-Camine
Original Assignee
Eukarion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eukarion Inc filed Critical Eukarion Inc
Publication of OA09893A publication Critical patent/OA09893A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA60481A 1992-07-13 1994-03-11 Transvascular and intracellular delivery of lipidized proteins. OA09893A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91245392A 1992-07-13 1992-07-13

Publications (1)

Publication Number Publication Date
OA09893A true OA09893A (en) 1994-09-15

Family

ID=25431949

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60481A OA09893A (en) 1992-07-13 1994-03-11 Transvascular and intracellular delivery of lipidized proteins.

Country Status (10)

Country Link
EP (1) EP0607408A4 (en)
JP (1) JPH07502753A (en)
KR (2) KR100372119B1 (en)
AU (1) AU4772793A (en)
CA (1) CA2118586A1 (en)
FI (1) FI941169A (en)
NZ (1) NZ255043A (en)
OA (1) OA09893A (en)
RU (1) RU2157239C2 (en)
WO (1) WO1994001131A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827819A (en) 1990-11-01 1998-10-27 Oregon Health Sciences University Covalent polar lipid conjugates with neurologically active compounds for targeting
US5543390A (en) 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
AU707947B2 (en) * 1995-07-21 1999-07-22 Promega Biosciences, Inc. Novel amide-based cationic lipids
US7045543B2 (en) 2001-11-05 2006-05-16 Enzrel Inc. Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
WO2003057728A1 (en) 2002-01-10 2003-07-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A novel splice variant of myd88 and uses thereof
US20060233790A1 (en) * 2002-03-22 2006-10-19 Shiroh Futaki Immunoglobulin/hydrophilic peptide complexes
CA2900876A1 (en) 2004-12-22 2006-08-17 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
EP1983823A1 (en) 2006-01-17 2008-10-29 VIB vzw Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration
US8217145B2 (en) * 2006-03-16 2012-07-10 The Scrips Research Institute Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
FI3851447T3 (en) 2006-10-12 2023-11-15 Bellus Health Inc Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US8173423B2 (en) 2006-11-07 2012-05-08 Vib Vzw Diagnosis and treatment of T-cell acute lymphoblastic leukemia
EP2096121A1 (en) * 2008-02-29 2009-09-02 Institut Pasteur Of Shanghai Antiviral peptides comprising lipid attachment signals and methods of use
EP2342356A4 (en) 2008-09-29 2012-11-21 Univ Ben Gurion Amyloid beta-peptides and methods of use thereof
WO2012001178A1 (en) 2010-07-02 2012-01-05 Vib Vzw The role of fragile x mental retardation gene and protein in cancer metastasis
GB201012845D0 (en) 2010-07-30 2010-09-15 Vib Vzw Inhibition of dicer function for treatment of cancer
AR083495A1 (en) * 2010-10-22 2013-02-27 Esbatech Alcon Biomed Res Unit STABLE AND SOLUBLE ANTIBODIES
EP2756005B1 (en) 2011-09-14 2016-03-02 Abeterno Technologies Limited Intracellular cell selection
WO2013121042A1 (en) 2012-02-16 2013-08-22 Vib Vzw PP2A SUBUNITS IN DNA REPAIR, THE PP2A B55α SUBUNIT AS NOVEL PHD2 INTERACTING PROTEIN, AND IMPLICATIONS FOR CANCER
GB201306589D0 (en) 2013-04-11 2013-05-29 Abeterno Ltd Live cell imaging
JP6736464B2 (en) 2013-08-29 2020-08-05 シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ Cell-permeable conjugates and methods of use thereof
KR101470793B1 (en) * 2014-06-30 2014-12-08 순천향대학교 산학협력단 Peptide as permeation enhancer and composition including the same
EP3634978A1 (en) 2017-06-07 2020-04-15 Adrx, Inc. Tau aggregation inhibitors
WO2019036725A2 (en) 2017-08-18 2019-02-21 Adrx, Inc. Tau aggregation peptide inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4429008B1 (en) * 1981-12-10 1995-05-16 Univ California Thiol reactive liposomes
EP0306912A3 (en) * 1987-09-08 1989-07-05 Albany Medical College Immunogenic composites capable of selectively inducing antibody production and pharmaceutical compositions employing the same.
CA2049028A1 (en) * 1989-03-07 1990-09-08 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
WO1991000289A2 (en) * 1989-06-23 1991-01-10 The Liposome Company, Inc. Targeted liposomes and methods for liposome-protein coupling
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
KR0181295B1 (en) * 1990-07-24 1999-04-01 야마타니 와타루 Phospholipid -or lipid-combining glycosaminoglycan production thereof and cancer metastasis inhibitor

Also Published As

Publication number Publication date
NZ255043A (en) 1997-03-24
FI941169A (en) 1994-05-04
FI941169A0 (en) 1994-03-11
KR20030097604A (en) 2003-12-31
EP0607408A4 (en) 1997-12-10
JPH07502753A (en) 1995-03-23
KR100372119B1 (en) 2003-06-28
CA2118586A1 (en) 1994-01-20
EP0607408A1 (en) 1994-07-27
RU2157239C2 (en) 2000-10-10
WO1994001131A1 (en) 1994-01-20
AU4772793A (en) 1994-01-31
RU94024566A (en) 1996-09-27

Similar Documents

Publication Publication Date Title
EP0607408A4 (en) Transvascular and intracellular delivery of lipidized proteins.
EP1043335A4 (en) Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
ZA962116B (en) Protein production and delivery
EP0681491A4 (en) Intrapulmonary delivery of hormones.
EP0745396A3 (en) Blood pump and application thereof
AU675760B2 (en) Reciprocating floor conveyor and floor member
AU1088399A (en) F-box proteins and genes
EP0805161A4 (en) (1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody
EP0426408A3 (en) Combined container and pump
HK1010153A1 (en) Recombinant human alpha-fetoprotein and uses thereof.
AU6750594A (en) Receptors of interleukin-12 and antibodies
AU6266896A (en) Transvacular and intracellular delivery of lipidized protein s
EP0653162A4 (en) Colletotrichum and use thereof.
AU8168898A (en) Interferon stimulating protein and uses thereof
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
EP0817967A4 (en) Insulin mimetic and enhancer assay
GB2336844B (en) Anti-hiv peptides and proteins
AU7352396A (en) Use of protein S-100b in medicines and medicines containing the protein S-100-b
AU2372197A (en) Transvascular and intracellular delivery of lipidized proteins
EP0602601A3 (en) Stable antibody solution and stabilization of antibody.
HUP9602220A2 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
AU8603591A (en) Peptide and its use
NO940877L (en) Transvascular and intracellular delivery of lipidized proteins
AU6269190A (en) Antibodies and proteins
EP0596725A3 (en) Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof.